Drug Database
Back to search

United States· US:65597-203_dc54247c-0158-4cae-b692-914717ab3a67

SAVAYSA

A edoxaban product containing edoxaban tosylate, registered in United States by Daiichi Sankyo Inc.. The same ATC class is registered in 17 of our 19 countries.

ATC B01AF03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSAVAYSAATCB01AF03REGISTER NO.US:65597-203_dc54247c…PACKS LISTED14CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about edoxaban tosylateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Edoxaban is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AF03 (edoxaban), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose
Search edoxaban products by name

Edoxaban · ATC B01AF03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of edoxaban costs, country by country.

Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Edoxaban · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • IT Italy$7.87
  • CH Switzerland$6.81
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
EDOXABAN TOSYLATE
Manufacturer
Daiichi Sankyo Inc.
Country
United States (US)
ATC code
B01AF03
ATC class
Edoxaban
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 14

  • ndc11
    65597-203-05
  • ndc11
    65597-203-07
  • ndc11
    65597-203-10
  • ndc11
    65597-203-30
  • ndc11
    65597-203-50
  • ndc11
    65597-203-70
  • ndc11
    65597-203-90
  • ndc11
    6559720305
    50 BLISTER PACK in 1 CARTON (65597-203-05) / 1 TABLET, FILM COATED in 1 BLISTER PACK
  • ndc11
    6559720307
    7 TABLET, FILM COATED in 1 BOTTLE (65597-203-07)
  • ndc11
    6559720310
    100 BLISTER PACK in 1 CARTON (65597-203-10) / 1 TABLET, FILM COATED in 1 BLISTER PACK
  • ndc11
    6559720330
    30 TABLET, FILM COATED in 1 BOTTLE (65597-203-30)
  • ndc11
    6559720350
    500 TABLET, FILM COATED in 1 BOTTLE (65597-203-50)
  • ndc11
    6559720370
    7 TABLET, FILM COATED in 1 BLISTER PACK (65597-203-70)
  • ndc11
    6559720390
    90 TABLET, FILM COATED in 1 BOTTLE (65597-203-90)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

262 interactions on record for edoxaban.

Graded by severity as the source publishes them — 182 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check edoxaban against other medicinesHow interaction checks work

Edoxaban · interactions on record

262 records

  • 182 severe
  • 80 moderate

Most severe, free to view

  • RolapitantA04AD14severe
  • EliglustatA16AX10severe
  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Edoxaban in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All edoxaban products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Edoflusio, Edoxaban !@ctavis
  • Belgium · Edoxaban Hcs, Edoxaban Sandoz
  • Bulgaria · Edoflusio, Делианда
  • Czechia · Delianda, Edoxaban +pharma
  • Germany · Edoxaban 1 A Pharma, Edoxaban 123 Acurae Pharma
  • Denmark · Arelzamio, Dijuga
  • Estonia · Delianda, Edoflusio
  • Spain · Edoxabán Almus, Edoxabán Cinfa
  • Finland · Edoxaban Avansor, Edoxaban Krka
  • France · Oblonela
  • United Kingdom (Northern Ireland) · Edoxaban, Edoxaban Accord
  • Greece · Delianda, Edoxaban Pharmapath
  • Croatia · Cagluen, Delianda
  • Hungary · Cagluen, Delianda
  • Ireland · Edoxaban Accord, Edoxaban Krka
  • Iceland · Edoxaban Accord, Edoxaban Krka
  • Italy · Edoxaban Dr. Reddy’s, Edoxaban Hcs
  • Liechtenstein · Lixiana, Roteas
  • Lithuania · Delianda, Edoflusio
  • Luxembourg · Oblonela
  • Latvia · Delianda, Edoflusio
  • Malta · Arelzamio, Dijuga
  • Netherlands · Edoxaban Cipla, Edoxaban G.L. Pharma
  • Norway · Edoxaban Krka, Edoxaban Sandoz
  • Poland · Delianda, Edoflusio
  • Portugal · Edoxabano Bluepharma, Edoxabano Kern Pharma
  • Romania · Cagluen, Delianda
  • Sweden · Edoflusio, Edoxaban Avansor
  • Slovenia · Delianda, Edoflusio
  • Slovakia · Delianda, Edoxaban Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa53279b-6bf7-410e-be54-5b64d2d47066
GET /v1/drugs/aa53279b-6bf7-410e-be54-5b64d2d47066?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "60",
  "substance": "EDOXABAN TOSYLATE",
  "productndc": "65597-203",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA206316",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about edoxaban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console